lodoxamide ethyl has been researched along with piperidines in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schwab, IR | 1 |
Trayner, EM | 1 |
Joseph Titi, M | 1 |
Couturier, C; Goldschmidt, P; Haeffner-Cavaillon, N; Herman, D; Kazatchkine, M | 1 |
Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
1 review(s) available for lodoxamide ethyl and piperidines
Article | Year |
---|---|
A critical look at ocular allergy drugs.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Ketorolac Tromethamine; Oxamic Acid; Piperidines; Tolmetin; Tromethamine | 1996 |
4 other study(ies) available for lodoxamide ethyl and piperidines
Article | Year |
---|---|
Nonsteroidal eye drops for ocular allergy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Drug Combinations; Histamine H1 Antagonists; Humans; Ketorolac Tromethamine; Ophthalmic Solutions; Oxamic Acid; Piperidines; Tolmetin; Tromethamine | 1994 |
Topical update: new medications for ocular allergy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Ophthalmic Solutions; Oxamic Acid; Piperidines; United States; United States Food and Drug Administration | 1994 |
Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
Topics: Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Basophil Degranulation Test; Basophils; Cell Degranulation; Complement C5; Cromolyn Sodium; Dipeptides; Enzyme-Linked Immunosorbent Assay; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Ophthalmic Solutions; Oxamic Acid; Piperidines; Recombinant Proteins | 1997 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |